Literature DB >> 9718198

TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells.

K Kurokouchi1, F Kambe, K Yasukawa, R Izumi, N Ishiguro, H Iwata, H Seo.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) plays a key role in inflammatory diseases such as rheumatoid arthritis and in postmenopausal osteoporosis. In various tissues, TNF-alpha action is mediated by a transcription factor, nuclear factor-kappa B (NF-kappaB). However, little is known about how TNF-alpha exerts its action in osteoblasts. We thus examined the effect of TNF-alpha on the activation of NF-kappaB in rat osteoblast-like osteosarcoma cells (ROS17/2.8). Electrophoretic mobility shift assay revealed that the activation of the p50-p65 heterodimer NF-kappaB was induced by TNF-alpha as early as 15 minutes followed by a persistent activation for 48 h. When the binding activity of NF-kappaB in cytosol was examined using detergents that dissociate NF-kappaB from an inhibitory protein IkappaB, it decreased during the initial 30 minutes and then increased to the unstimulated level. Northern blot analysis revealed a marked increase in the mRNA levels of p105, a precursor of p50, 6 h after TNF-alpha and a gradual increase in p65 mRNA levels during the initial 1 h. Significant increase in both mRNA levels continued until 24 h after TNF-alpha. These results suggest that the rapid activation of NF-kappaB by TNF-alpha is mainly due to the nuclear translocation of NF-kappaB pre-existing in cytosol, and that the subsequent increase in the expression of p50 and p65 may result in the persistent activation of NF-kappaB during TNF-alpha stimulation. TNF-alpha also increased the mRNA levels of interleukin-6 (IL-6) and intercellular adhesion molecule-1 (ICAM-1). An antioxidant, N-acetyl-L-cysteine, significantly attenuated the TNF-alpha-dependent increase in these mRNAs, and simultaneously reduced the activation of NF-kappaB by TNF-alpha, indicating that NF-kappaB mediates the TNF-alpha-dependent expression of IL-6 and ICAM-1 in ROS17/2.8 cells. These results suggest that the activation of NF-kappaB by TNF-alpha may play an important role in the production of cytokines and cell adhesion molecules from osteoblasts, leading to the promotion of bone resorption and inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718198     DOI: 10.1359/jbmr.1998.13.8.1290

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  27 in total

Review 1.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

2.  Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway.

Authors:  Wei Huang; Wei-lin Shang; Hua-dong Wang; Wen-wen Wu; Shu-xun Hou
Journal:  Acta Pharmacol Sin       Date:  2012-03-26       Impact factor: 6.150

3.  Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line.

Authors:  T Kikumori; F Kambe; T Nagaya; H Funahashi; H Seo
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

4.  Involvement of reactive oxygen species in cyclic stretch-induced NF-kappaB activation in human fibroblast cells.

Authors:  Hideki Amma; Keiji Naruse; Naoki Ishiguro; Masahiro Sokabe
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis.

Authors:  Armandina Garza; David J Tweardy; Joel Weinstock; Balaji Viswanathan; Prema Robinson
Journal:  J Biomed Biotechnol       Date:  2010-01-28

6.  A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.

Authors:  Kathleen A Bishop; Mark B Meyer; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-10-30

Review 7.  Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer.

Authors:  Tristan M Sissung; Silja Thordardottir; Erin R Gardner; William D Figg
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

8.  Up-regulated isocitrate dehydrogenase 1 suppresses proliferation, migration and invasion in osteosarcoma: in vitro and in vivo.

Authors:  Xiang Hu; Yang Liu; Chunxia Qin; Zhenyu Pan; Jun Luo; Aixi Yu; Zhen Cheng
Journal:  Cancer Lett       Date:  2013-12-22       Impact factor: 8.679

9.  Treatment with hydrogen molecule alleviates TNFα-induced cell injury in osteoblast.

Authors:  Wen-Wen Cai; Ming-Hua Zhang; Yong-Sheng Yu; Jin-Hua Cai
Journal:  Mol Cell Biochem       Date:  2012-12-01       Impact factor: 3.396

10.  Aflatoxin B1 modulates the expression of phenotypic markers and cytokines by splenic lymphocytes of male F344 rats.

Authors:  Guoqing Qian; Lili Tang; Xia Guo; Franklin Wang; Michael E Massey; Jianjia Su; Tai L Guo; Jonathan H Williams; Timothy D Phillips; Jia-Sheng Wang
Journal:  J Appl Toxicol       Date:  2013-03-19       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.